Gcp-service International West Gmbh

This study tests a drug called imetelstat in people with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) whose cancer did not respond to standard treatments. The goal is to see if the drug can improve blood cell counts and control the disease. Participan…